4.5 Article

Mice with cardiac-restricted overexpression of Myozap are sensitized to biomechanical stress and develop a protein-aggregate-associated cardiomyopathy

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2014.03.016

关键词

Intercalated disc; Cardiomyopathy; Transgenic mouse model; SRF; Protein aggregates

资金

  1. Bundesministerium fur Bildung und Forschung (BMBF/NGFNplus) [BMBF/01GS0902]

向作者/读者索取更多资源

The intercalated disc (ID) is a major component of the cell-cell contact structures of cardiomyocytes and has been recognized as a hot spot for cardiomyopathy. We have previously identified Myozap as a novel cardiac-enriched ID protein, which interacts with several other ID proteins and is involved in RhoA/SRF signaling in vitro. To now study its potential role in vivo we generated a mouse model with cardiac overexpression of Myozap. Transgenic (Tg) mice developed cardiomyopathy with hypertrophy and LV dilation. Consistently, these mice displayed upregulation of the hypertrophy-associated and SRF-dependent gene expression. Pressure overload (transverse aortic constriction, TAC) caused exaggerated cardiac hypertrophy, further loss of contractility and LV dilation. Similarly, a physiological stimulus (voluntary running) also led to significant LV dysfunction. On the ultrastructural level, Myozap-Tg mouse hearts exhibited massive protein aggregates composed of Myozap, desmoplakin and other ID proteins. This aggregate-associated pathology closely reserribled the alterations observed in desmin-related cardiomyopathy. Interestingly, desmin was not detectable in the aggregates, yet was largely displaced from the ID. Molecular analyses revealed induction of autophagy and dysregulation of the unfolded protein response (UPR), associated with apoptosis. Taken together, cardiac overexpression of Myozap leads to cardiomyopathy, mediated, at least in part by induction of Rho-dependent SRF signaling in vivo. Surprisingly, this phenotype was also accompanied by protein aggregates in cardiomyocytes, UPR alteration, accelerated autophagy and apoptosis. Thus, this mouse model may also offer additional insight into the pathogenesis of protein-aggregate-associated cardiomyopathies and represents a new candidate gene itself. (C) 2014 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Drop in oxygen saturation and blood pressure as well as increase in central venous pressure during mitral valve clipping in an 81-year-old female patient

Martin J. Volz, Matthias Aurich, Mathias Konstandin, Hugo A. Katus, Norbert Frey, Michael M. Kreusser, Philip W. Raake

Summary: This case report highlights the hemodynamic changes caused by atrial septal defects (ASD) following endovascular mitral valve clipping. Immediate closure using an atrial septal occluder successfully restored the oxygen saturation and hemodynamic parameters.

INTERNIST (2022)

Article Cardiac & Cardiovascular Systems

Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure

Vitali Koch, Christophe Weber, Johannes H. Riffel, Kristina Buchner, Sebastian J. Buss, Selina Hein, Derliz Mereles, Marco Hagenmueller, Christian Erbel, Winfried Marz, Christian Booz, Moritz H. Albrecht, Thomas J. Vogl, Norbert Frey, Stefan E. Hardt, Marco Ochs

Summary: Dietary supplementation of the amino acid homoarginine (HA) may prevent cardiac remodeling and improve heart function in the setting of chronic kidney disease. HA treatment in rats undergoing 5/6 nephrectomy (5/6 Nx) led to improvements in ejection fraction, fractional shortening, and decreased myocardial fibrosis, left ventricular weight, and myocyte cross-sectional area. These changes were accompanied by downregulation of specific molecular factors related to heart function.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2022)

Letter Clinical Neurology

COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2

Brigitte Wildemann, Sven Jarius, Lorenz H. Lehmann, Florian Andre, Norbert Frey, Paul Schnitzler, Laura Jaeger, Christoph Gumbinger, Andrea Viehover

JOURNAL OF NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Heart Failure Severity Closely Correlates with Intestinal Dysbiosis and Subsequent Metabolomic Alterations

Martina E. Spehlmann, Ashraf Y. Rangrez, Dhiraj P. Dhotre, Nesrin Schmiedel, Nikita Chavan, Corinna Bang, Oliver J. Mueller, Yogesh S. Shouche, Andre Franke, Derk Frank, Norbert Frey

Summary: Growing evidence suggests that patients with heart failure (HF) have an altered gut microbiome. This study used a mouse model to investigate the association between the severity and progression of HF and the composition of gut microbiome and circulating metabolites. The results showed that gut bacterial diversity was significantly lower in mice with HF compared to controls, and the abundance and grouping of several bacteria differed based on the severity of cardiac dysfunction. Metabolic alterations, such as reduced short-chain fatty acids and an increase in primary bile acids, were strongly correlated with the differential abundance of distinct bacteria in HF.

BIOMEDICINES (2022)

Article Multidisciplinary Sciences

Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy

Namrita Kaur, Andrea Ruiz-Velasco, Rida Raja, Gareth Howell, Jessica M. Miller, Riham R. E. Abouleisa, Qinghui Ou, Kimberly Mace, Susanne S. Hille, Norbert Frey, Pablo Binder, Craig P. Smith, Helene Fachim, Handrean Soran, Eileithyia Swanton, Tamer M. A. Mohamed, Oliver J. Mueller, Xin Wang, Jonathan Chernoff, Elizabeth J. Cartwright, Wei Liu

Summary: Myocardial inflammation contributes to cardiomyopathy in diabetic patients, primarily through inflammation induced by abnormal ER. Studies have revealed that ER stress-induced CHOP is a novel regulator of HMGB1 in the heart, with HMGB1 release promoting macrophage polarization and aggravating myocardial inflammation.

ISCIENCE (2022)

Article Cardiac & Cardiovascular Systems

Pak2 Regulation of Nrf2 Serves as a Novel Signaling Nexus Linking ER Stress Response and Oxidative Stress in the Heart

Pablo Binder, Binh Nguyen, Lucy Collins, Min Zi, Wei Liu, Foteini Christou, Xiaojing Luo, Susanne S. Hille, Norbert Frey, Elizabeth J. Cartwright, Jonathan Chernoff, Oliver J. Mueller, Kaomei Guan, Xin Wang

Summary: This study identifies a novel regulator of Nrf2, Pak2, and elucidates the potential therapeutic significance of Pak2-mediated regulation of Nrf2 homeostasis in alleviating ER stress and heart failure.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

The obesity paradox in heart failure: is it still valid in light of new therapies?

Hanna Froehlich, Norbert Frey, Lutz Frankenstein, Tobias Taeger

Summary: This article discusses the obesity paradox in patients with heart failure (HF) and the potential interference of new HF treatments, such as SGLT2 inhibitors. The literature provides evidence for the obesity paradox in various HF patients, and it has been observed in SGLT2 inhibitor-treated patients but not in those using sacubitril/valsartan. Cardiorespiratory fitness and HF severity appear to be important factors influencing the obesity paradox in HF. Unintentional weight loss is associated with a poor prognosis, but weight loss associated with SGLT2 inhibitor treatment appears to be safe.

CARDIOLOGY (2022)

Letter Cardiac & Cardiovascular Systems

Letter by Giannitsis et al Regarding Article, Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T

Evangelos Giannitsis, Hugo A. Katus, Norbert Frey

CIRCULATION (2022)

Review Cardiac & Cardiovascular Systems

A practical approach to the guideline-directed pharmacological treatment of heart failure with reduced ejection fraction

Amr Abdin, Johann Bauersachs, Samira Soltani, Matthias Eden, Norbert Frey, Michael Boehm

Summary: Heart failure remains a global healthcare challenge despite significant developments in pharmacotherapies. There are concerns regarding low medication dosages and incomplete drug classes in real-world settings, and current guidelines lack detailed recommendations. A practical approach algorithm is proposed to assist physicians in treating HF patients.

ESC HEART FAILURE (2023)

Article Multidisciplinary Sciences

Dataset of ileum bacterial diversity in mice after heart failure due to pressure overload

Martina E. Spehlmann, Dhiraj P. Dhotre, Nesrin Schmiedel, Nikita Chavan, Corinna Bang, Ashraf Y. Rangrez

Summary: This study reports the correlation between gut bacterial diversity and heart failure. The results from a mouse model experiment show that the severity of heart failure is closely correlated with gut bacterial diversity.

DATA IN BRIEF (2022)

Article Pharmacology & Pharmacy

Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding

Panagiotis Xynogalos, Ann-Kathrin Rahm, Sebastian Fried, Safak Chasan, Daniel Scherer, Claudia Seyler, Hugo A. Katus, Norbert Frey, Edgar Zitron

Summary: This study analyzed the effect of the antiarrhythmic drug verapamil on the inwardly rectifying potassium current of cardiomyocytes. The results showed that verapamil inhibited the Kir2.1, Kir2.2, and Kir2.3 channels, with the inhibition of Kir2.3 being a previously unknown finding. Further experiments revealed that the inhibition of Kir2.3 by verapamil was dependent on specific binding sites and interference with PIP2 activation. This finding provides a potential target for the development of selective antiarrhythmic drugs targeting Kir2.3 channels.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity

Kunika, Norbert Y. Frey, Ashraf Rangrez

Summary: Recent technological advancements have increased our understanding of the human microbiome, which plays a role in both health and disease progression, including cancer and heart disease. The microbiome may potentially be targeted in cancer therapy to improve treatment effectiveness. Additionally, the altered microbiome composition caused by cancer treatment is linked to long-term effects and can lead to gastrointestinal toxicity. The relationship between the microbiome and cardiac diseases in cancer patients following therapy is poorly understood.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cardiac & Cardiovascular Systems

Case report of an S-ICD implantation for secondary prevention in a patient with complex congenital heart disease, dextrocardia, and situs solitus

Felix Wiedmann, Raffaele De Simone, Peter Rose, Matthias Karck, Matthias Gorenflo, Norbert Frey, Constanze Schmidt

Summary: This case report presents a successful implantation of a subcutaneous ICD in a young female patient with dextrocardia and situs solitus, indicating the feasibility of left S-ICD implantation even in the presence of anatomical abnormalities commonly associated with this condition.

EUROPEAN HEART JOURNAL-CASE REPORTS (2022)

Review Cell Biology

SRF: a seriously responsible factor in cardiac development and disease

Anushka Deshpande, Prithviraj Manohar Vijaya Shetty, Norbert Frey, Ashraf Yusuf Rangrez

Summary: This article discusses the molecular mechanisms that regulate cardiac development and adult cardiac homeostasis, focusing on the role of SRF and its potential therapeutic applications.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Meeting Abstract Medicine, General & Internal

Alcohol Consumption as another Risk Factor of TakoTsubo Cardiomyopathy - A monocentric Study

Lara Kluemper, Matthias Lutz, Norbert Frey

INTERNIST (2022)

Article Cardiac & Cardiovascular Systems

Epicardial deletion of Sox9 leads to myxomatous valve degeneration and identifies Cd109 as a novel gene associated with valve development

Andrew B. Harvey, Renelyn A. Woltes, Raymond N. Deepe, Hannah G. Tarolli, Jenna R. Drummond, Allison Trouten, Auva Zandi, Jeremy L. Barth, Rupak Mukherjee, Martin J. Romeo, Silvia G. Vaena, Ge Tao, Robin Muise-Helmericks, Paula S. Ramos, Russell A. Norris, Andy Wessels

Summary: This study highlights the importance of SOX9 in the regulation of epicardial cell invasion and emphasizes the role of EPDCs in regulating atrioventricular valve development and homeostasis. It also reports a novel expression profile of Cd109, a gene with previously unknown relevance in heart development.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Review Cardiac & Cardiovascular Systems

Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases

MariaSanta C. Mangione, Jinhua Wen, Dian J. Cao

Summary: mTOR, a mechanistic target of rapamycin, is an evolutionarily conserved pathway that plays a fundamental role in nutrient sensing, growth, metabolism, lifespan, and aging. Recent studies have highlighted the regulatory role of mTOR in innate immune responses and its involvement in the pathogenesis of cardiovascular diseases, especially in acute inflammation and atherosclerotic cardiovascular disease. This review also discusses mTOR's role in trained immunity, immune senescence, and clonal hematopoiesis, as well as its architecture and regulatory complexes.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Classification of regulatory T cells and their role in myocardial ischemia-reperfusion injury

Junlin Li, Yajun Gong, Yiren Wang, Huihui Huang, Huan Du, Lianying Cheng, Cui Ma, Yongxiang Cai, Hukui Han, Jianhong Tao, Gang Li, Panke Cheng

Summary: Myocardial ischemia-reperfusion injury is closely related to the final infarct size in acute myocardial infarction. Regulatory T cells play an important role in the inflammatory response after AMI, but different subtypes of Tregs have different effects on the injury.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

β-hydroxybutyrate administered at reperfusion reduces infarct size and preserves cardiac function by improving mitochondrial function through autophagy in male mice

Yuxin Chu, Yutao Hua, Lihao He, Jin He, Yunxi Chen, Jing Yang, Ismail Mahmoud, Fanfang Zeng, Xiaochang Zeng, Gloria A. Benavides, Victor M. Darley-Usmar, Martin E. Young, Scott W. Ballinger, Sumanth D. Prabhu, Cheng Zhang, Min Xie

Summary: This study demonstrates that administering beta-hydroxybutyrate (beta-OHB) at the time of reperfusion can reduce infarct size and preserve cardiac function by activating autophagy and preserving mitochondrial homeostasis, potentially through mTOR inhibition.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)